APO RESEARCH · REPORT
Apomorphine Hydrochloride
Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
Product & engineering
Understand the product.
Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
Selected research
Market Structure
Global Apomorphine Hydrochloride Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025.
Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%.
Read the full market overview
Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%.
Market competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report provides an overview of the global Apomorphine Hydrochloride market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Apomorphine Hydrochloride and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Apomorphine Hydrochloride sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Apomorphine Hydrochloride market size, projected growth trends, production technologies, key applications, and end-use industries.
Apomorphine Hydrochloride Segment by Company
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)
Tianjin Tianwei Pharmaceutical
Sunovion
Apomorphine Hydrochloride Segment by Type
Injection
Tablets
Thinfilm
Nasal Powder (Pipeline)
Apomorphine Hydrochloride Segment by Application
Parkinson Disease
Erectile Dysfunction
Apomorphine Hydrochloride Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Apomorphine Hydrochloride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Apomorphine Hydrochloride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Apomorphine Hydrochloride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Apomorphine Hydrochloride market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Apomorphine Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Apomorphine Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Apomorphine Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Tablets
- Thinfilm
- Nasal Powder (Pipeline)
Applications
- Parkinson Disease
- Erectile Dysfunction
Companies covered
- Supernus Pharmaceuticals
- Britannia Pharmaceuticals STADA
- Ever Pharma
- Evolan Pharma AB (PharmSwed)
- Tianjin Tianwei Pharmaceutical
- Sunovion
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Apomorphine Hydrochloride Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Apomorphine Hydrochloride Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Apomorphine Hydrochloride Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Apomorphine Hydrochloride Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Apomorphine Hydrochloride Market Dynamics
- 2.1 Apomorphine Hydrochloride Industry Trends
- 2.2 Apomorphine Hydrochloride Industry Drivers
- 2.3 Apomorphine Hydrochloride Industry Opportunities and Challenges
- 2.4 Apomorphine Hydrochloride Industry Restraints
3 Apomorphine Hydrochloride Market by Manufacturers
- 3.1 Global Apomorphine Hydrochloride Revenue by Manufacturers (2021-2026)
- 3.2 Global Apomorphine Hydrochloride Sales by Manufacturers (2021-2026)
- 3.3 Global Apomorphine Hydrochloride Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Apomorphine Hydrochloride Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Apomorphine Hydrochloride Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Apomorphine Hydrochloride Manufacturers, Product Type & Application
- 3.7 Global Apomorphine Hydrochloride Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Apomorphine Hydrochloride Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Apomorphine Hydrochloride Players Market Share by Revenue in 2025
- 3.8.3 2025 Apomorphine Hydrochloride Tier 1, Tier 2, and Tier 3
4 Apomorphine Hydrochloride Market by Type
- 4.1 Apomorphine Hydrochloride Type Introduction
- 4.1.1 Injection
- 4.1.2 Tablets
- 4.1.3 Thinfilm
- 4.1.4 Nasal Powder (Pipeline)
- 4.2 Global Apomorphine Hydrochloride Sales by Type
- 4.2.1 Global Apomorphine Hydrochloride Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Apomorphine Hydrochloride Sales by Type (2021-2032)
- 4.2.3 Global Apomorphine Hydrochloride Sales Market Share by Type (2021-2032)
- 4.3 Global Apomorphine Hydrochloride Revenue by Type
- 4.3.1 Global Apomorphine Hydrochloride Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Apomorphine Hydrochloride Revenue by Type (2021-2032)
- 4.3.3 Global Apomorphine Hydrochloride Revenue Market Share by Type (2021-2032)
5 Apomorphine Hydrochloride Market by Application
- 5.1 Apomorphine Hydrochloride Application Introduction
- 5.1.1 Parkinson Disease
- 5.1.2 Erectile Dysfunction
- 5.2 Global Apomorphine Hydrochloride Sales by Application
- 5.2.1 Global Apomorphine Hydrochloride Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Apomorphine Hydrochloride Sales by Application (2021-2032)
- 5.2.3 Global Apomorphine Hydrochloride Sales Market Share by Application (2021-2032)
- 5.3 Global Apomorphine Hydrochloride Revenue by Application
- 5.3.1 Global Apomorphine Hydrochloride Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Apomorphine Hydrochloride Revenue by Application (2021-2032)
- 5.3.3 Global Apomorphine Hydrochloride Revenue Market Share by Application (2021-2032)
6 Global Apomorphine Hydrochloride Sales by Region
- 6.1 Global Apomorphine Hydrochloride Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Apomorphine Hydrochloride Sales by Region (2021-2032)
- 6.2.1 Global Apomorphine Hydrochloride Sales by Region (2021-2026)
- 6.2.2 Global Apomorphine Hydrochloride Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Apomorphine Hydrochloride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Apomorphine Hydrochloride Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Apomorphine Hydrochloride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Apomorphine Hydrochloride Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Apomorphine Hydrochloride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Apomorphine Hydrochloride Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Apomorphine Hydrochloride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Apomorphine Hydrochloride Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Apomorphine Hydrochloride Revenue by Region
- 7.1 Global Apomorphine Hydrochloride Revenue by Region
- 7.1.1 Global Apomorphine Hydrochloride Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Apomorphine Hydrochloride Revenue by Region (2021-2026)
- 7.1.3 Global Apomorphine Hydrochloride Revenue by Region (2027-2032)
- 7.1.4 Global Apomorphine Hydrochloride Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Apomorphine Hydrochloride Revenue (2021-2032)
- 7.2.2 North America Apomorphine Hydrochloride Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Apomorphine Hydrochloride Revenue (2021-2032)
- 7.3.2 Europe Apomorphine Hydrochloride Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Apomorphine Hydrochloride Revenue (2021-2032)
- 7.4.2 Asia-Pacific Apomorphine Hydrochloride Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Apomorphine Hydrochloride Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Apomorphine Hydrochloride Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Supernus Pharmaceuticals
- 8.1.1 Supernus Pharmaceuticals Company Information
- 8.1.2 Supernus Pharmaceuticals Business Overview
- 8.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Supernus Pharmaceuticals Apomorphine Hydrochloride Product Portfolio
- 8.1.5 Supernus Pharmaceuticals Recent Developments
- 8.2 Britannia Pharmaceuticals STADA
- 8.2.1 Britannia Pharmaceuticals STADA Company Information
- 8.2.2 Britannia Pharmaceuticals STADA Business Overview
- 8.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product Portfolio
- 8.2.5 Britannia Pharmaceuticals STADA Recent Developments
- 8.3 Ever Pharma
- 8.3.1 Ever Pharma Company Information
- 8.3.2 Ever Pharma Business Overview
- 8.3.3 Ever Pharma Apomorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Ever Pharma Apomorphine Hydrochloride Product Portfolio
- 8.3.5 Ever Pharma Recent Developments
- 8.4 Evolan Pharma AB (PharmSwed)
- 8.4.1 Evolan Pharma AB (PharmSwed) Company Information
- 8.4.2 Evolan Pharma AB (PharmSwed) Business Overview
- 8.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product Portfolio
- 8.4.5 Evolan Pharma AB (PharmSwed) Recent Developments
- 8.5 Tianjin Tianwei Pharmaceutical
- 8.5.1 Tianjin Tianwei Pharmaceutical Company Information
- 8.5.2 Tianjin Tianwei Pharmaceutical Business Overview
- 8.5.3 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product Portfolio
- 8.5.5 Tianjin Tianwei Pharmaceutical Recent Developments
- 8.6 Sunovion
- 8.6.1 Sunovion Company Information
- 8.6.2 Sunovion Business Overview
- 8.6.3 Sunovion Apomorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Sunovion Apomorphine Hydrochloride Product Portfolio
- 8.6.5 Sunovion Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Apomorphine Hydrochloride Value Chain Analysis
- 9.1.1 Apomorphine Hydrochloride Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Apomorphine Hydrochloride Production Mode & Process
- 9.2 Apomorphine Hydrochloride Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Apomorphine Hydrochloride Distributors
- 9.2.3 Apomorphine Hydrochloride Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst